Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-11, with 31 holding rows worth $469,017,000.

Accession
0001567619-20-009394
Filed
2020-05-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2020

A holdings report, 31 entries on the cover page, a total value of $469,017,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $469,017,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Bristol-Myers Squibb Company110122108COM677,433$37,760,000thousands by filing date
INCYTE CORP COM45337C102Stock452,583$33,143,000thousands by filing date
Boston Scientific Corporation101137107COM970,982$31,683,000thousands by filing date
Abbott Laboratories002824100COM370,334$29,223,000thousands by filing date
Merck & Co.,Inc.58933Y105COM372,695$28,675,000thousands by filing date
BIOGEN INC COM09062X103Stock75,120$23,766,000thousands by filing date
REVVITY INC714046109COM278,522$20,967,000thousands by filing date
Elevance Health, Inc.036752103COM89,602$20,343,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock256,716$18,386,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock356,240$17,132,000thousands by filing date
NUVASIVE INC670704105COM314,828$15,949,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock162,554$15,414,000thousands by filing date
Johnson & Johnson478160104COM117,532$15,412,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM168,503$15,130,000thousands by filing date
Gilead Sciences,Inc.375558103COM199,419$14,909,000thousands by filing date
HUMANA INC COM444859102Stock44,657$14,023,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock275,481$13,025,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM139,582$11,795,000thousands by filing date
BRUKER CORP116794108COM326,846$11,721,000thousands by filing date
BIO RAD LABS INC090572207CL A32,470$11,383,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock501,762$11,234,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM208,192$9,981,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock113,042$9,077,000thousands by filing date
PATTERSON COS INC703395103COM530,217$8,107,000thousands by filing date
CVS Health Corporation126650100COM120,860$7,171,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM145,072$6,446,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock54,384$5,920,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM75,996$3,390,000thousands by filing date
LIVANOVA PLCG5509L101SHS71,400$3,231,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM376,085$2,392,000thousands by filing date
BLUEBIRD BIO INC09609G100COM48,490$2,229,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-20-009394this filing2020-05-11acceptance time not in the bulk data set